ResMed Inc.
RMD Healthcare Medical Instruments & Supplies
ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025. In the quarter to June 2026, revenue grew 8.58%, EPS grew 2.32%, free cash flow fell 21.3% and total debt fell 39.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
Follow RMD
ResMed Inc. (RMD) P/E ratio
As of 16 October 2026, ResMed Inc. (RMD) trades at a P/E ratio of 22.8×. Over the past ten years it has ranged from 17.6× (June 2026) to 90.9× (September 2021); the current reading is higher than 10% of that period. That is below the Medical Instruments & Supplies industry median of 33.8× and in line with the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2026 | 18.6× | (31.04%) |
| FY2025 | 27.0× | 0.29% |
| FY2024 | 26.9× | (24.68%) |
| FY2023 | 35.8× | (9.07%) |
| FY2022 | 39.3× | (47.83%) |
| FY2021 | 75.4× | 69.23% |
| FY2020 | 44.5× | 1.87% |
| FY2019 | 43.7× | (6.45%) |
| FY2018 | 46.7× | 45.28% |
| FY2017 | 32.2× | 24.17% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 18.6× | (13.68%) |
| Mar 2026 | 21.6× | (9.04%) |
| Dec 2025 | 23.7× | (14.95%) |
| Sep 2025 | 27.9× | 3.29% |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| BAX Baxter International Inc. compare | n/m |
| SOLV Solventum Corporation compare | 10.4× |
| COO The Cooper Companies, Inc. compare | 19.8× |
| RMD ResMed Inc. | 22.8× |
| WST West Pharmaceutical Services, Inc. compare | 48.7× |
| ALC Alcon compare | 50.5× |
| BDX Becton, Dickinson and Company compare | 57.8× |
| RGEN Repligen Corporation compare | 234× |
| MDLN Medline Inc. compare | — |
| Medical Instruments & Supplies industry median | 33.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on RMD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement